Comparative efficacy and safety of novel Lp(a)-lowering therapies for ASCVD prevention: A network meta-analysis

Elevated lipoprotein(a) [Lp(a)] is a genetically determined and independent risk factor for atherosclerotic cardiovascular disease (ASCVD) that is largely resistant to conventional lipid-lowering therapies. Novel Lp(a)-targeted agents, including small interfering RNA (siRNA), antisense oligonucleoti...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	An-xin Wu, Xing-jin Wang, Chen Zhao, Jia-qiang Hu, Jin-wei Li, Ying Xu, Yi Li, Song Liu
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Elsevier 2026-05-01
Schriftenreihe:	Pharmacological Research
Schlagworte:	Small interfering RNA Antisense oligonucleotides Muvalaplin Lp(a) LDL-C Network Meta-Analysis
Online-Zugang:	http://www.sciencedirect.com/science/article/pii/S1043661826000939
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!